MXPA01007835A - Metodo para la prevencion o la reduccion de los eventos cardiovasculares asociados con la intervencion coronaria. - Google Patents

Metodo para la prevencion o la reduccion de los eventos cardiovasculares asociados con la intervencion coronaria.

Info

Publication number
MXPA01007835A
MXPA01007835A MXPA01007835A MXPA01007835A MXPA01007835A MX PA01007835 A MXPA01007835 A MX PA01007835A MX PA01007835 A MXPA01007835 A MX PA01007835A MX PA01007835 A MXPA01007835 A MX PA01007835A MX PA01007835 A MXPA01007835 A MX PA01007835A
Authority
MX
Mexico
Prior art keywords
approximately
further characterized
days
composition according
administered
Prior art date
Application number
MXPA01007835A
Other languages
English (en)
Spanish (es)
Inventor
Jeffrey R Granett
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MXPA01007835A publication Critical patent/MXPA01007835A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA01007835A 1999-02-03 2000-02-02 Metodo para la prevencion o la reduccion de los eventos cardiovasculares asociados con la intervencion coronaria. MXPA01007835A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11846299P 1999-02-03 1999-02-03
PCT/US2000/002622 WO2000045811A1 (fr) 1999-02-03 2000-02-02 Methode de prevention ou reduction d'incidents cardio-vasculaires associes a une intervention coronarienne

Publications (1)

Publication Number Publication Date
MXPA01007835A true MXPA01007835A (es) 2002-04-24

Family

ID=22378750

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01007835A MXPA01007835A (es) 1999-02-03 2000-02-02 Metodo para la prevencion o la reduccion de los eventos cardiovasculares asociados con la intervencion coronaria.

Country Status (17)

Country Link
EP (1) EP1171116A4 (fr)
JP (1) JP2002536327A (fr)
KR (1) KR20010101934A (fr)
CN (1) CN1345237A (fr)
AU (1) AU2636600A (fr)
BR (1) BR0007921A (fr)
CA (1) CA2361581A1 (fr)
CO (1) CO5150206A1 (fr)
HK (1) HK1045104A1 (fr)
HU (1) HUP0200129A3 (fr)
IL (1) IL144721A0 (fr)
MX (1) MXPA01007835A (fr)
NO (1) NO20013788L (fr)
PL (1) PL351397A1 (fr)
TR (1) TR200102245T2 (fr)
WO (1) WO2000045811A1 (fr)
ZA (1) ZA200106353B (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
AU6837096A (en) * 1995-09-07 1997-03-27 Kissei Pharmaceutical Co. Ltd. 2-acylaminobenzamide derivatives and preventive and remedy for diseases caused by the supermultiplication of vascular intimal cells
US6019104A (en) * 1996-12-30 2000-02-01 Kissei Pharmaceutical Co., Ltd. Method for the treatment or prevention of restenosis associated with coronary intervention

Also Published As

Publication number Publication date
KR20010101934A (ko) 2001-11-15
ZA200106353B (en) 2002-08-02
WO2000045811A1 (fr) 2000-08-10
CO5150206A1 (es) 2002-04-29
HUP0200129A2 (hu) 2002-05-29
TR200102245T2 (tr) 2002-05-21
PL351397A1 (en) 2003-04-07
BR0007921A (pt) 2002-09-10
HUP0200129A3 (en) 2003-06-30
EP1171116A4 (fr) 2004-11-17
CN1345237A (zh) 2002-04-17
HK1045104A1 (zh) 2002-11-15
NO20013788L (no) 2001-09-28
EP1171116A1 (fr) 2002-01-16
IL144721A0 (en) 2002-06-30
CA2361581A1 (fr) 2000-08-10
JP2002536327A (ja) 2002-10-29
NO20013788D0 (no) 2001-08-02
AU2636600A (en) 2000-08-25

Similar Documents

Publication Publication Date Title
CA2106172C (fr) Utilisation de l'acide 2-(3,4-dimethoxycinnamoyl)aminobenzoique pour le traitement de la restenose associee aux interventions coronariennes
TW389696B (en) Accelerated release composition containing bromocriptine
WO2003024450A1 (fr) Methodes de traitement des maladies a prions
EP1503755A1 (fr) Utilisation de zonisamide dans le traitement de l'obesite et des troubles alimentaires
WO2005084392A2 (fr) Formulations a base de 4-methylpyrazole destinees a inhiber l'intolerance a l'ethanol
US20030191137A1 (en) Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
JP3007992B2 (ja) （ｒ）−アムロジピンによる平滑筋細胞の遊走の抑制
AU2007234917B2 (en) Renin inhibitors for the treatment of hypertension
EP1190714A2 (fr) Méthode de traitment de troubles thromboemboliques chez des patients souffrant de résistance d'aspirine
MXPA01007835A (es) Metodo para la prevencion o la reduccion de los eventos cardiovasculares asociados con la intervencion coronaria.
WO2001062241A1 (fr) Procede permettant de prevenir ou reduire les dysfonctionnements de l'acces vasculaire
US4575506A (en) Method of treatment for inhibiting the tolerance onset while treating painful syndromes with central analgesics
MXPA01007833A (es) Metodo para prevenir o reducir eventos cardiovasculares asociados con intervencion de la arteria coronaria.
WO2001097798A1 (fr) Procede servant a prevenir ou a reduire des evenements cardio-vasculaires induits par intervention coronarienne
KR20070113532A (ko) 베르바민을 유효성분으로 포함하는 혈관 재협착 예방제
KR100806541B1 (ko) 아세클로페낙을 함유하는 제어 방출성 제제
AU627277B2 (en) A method of treatment or prevention of post-ptca restenosis by post-ptca restenosis inhibitor
US5354770A (en) Using imidazolyl tetrahydronaphthalene carboxylic acids to inhibit restenosis
JP2003504396A (ja) マクロライド化合物の新規用途
JP2005520806A (ja) がん治療を改善する併用療法におけるキナゾリノン化合物
Joseph et al. Recent therapeutic advances in leprosy and their implications in clinical practice
WO2002056941A2 (fr) Methode de traitement de l'acrosyndrome
JP2005289818A (ja) 動脈硬化抑制剤および治療剤